Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775698961> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2775698961 endingPage "507" @default.
- W2775698961 startingPage "499" @default.
- W2775698961 abstract "The aim of this pooled analysis of the TOZURA study programme was to evaluate the efficacy and safety of subcutaneous tocilizumab (TCZ-SC) as monotherapy or in combination with conventional synthetic DMARDs (csDMARDs) in patients with moderate to severe RA who had an inadequate response to csDMARD or anti-TNF agent therapy or who were MTX naïve. TOZURA is a multinational, open-label, single-arm, common-framework, phase 4 study programme (11 protocols, 22 countries). Patients received TCZ-SC 162 mg each week for ⩾24 weeks, administered at the investigator’s discretion, as monotherapy or in combination with a csDMARD. Efficacy, safety and immunogenicity were evaluated; propensity score–based matching was used for between-group comparisons. Of 1804 patients, 353 (19.6%) received monotherapy and 1451 (80.4%) received combination therapy. The 28-joint DAS using ESR (DAS28-ESR) in both groups decreased significantly from baseline to week 24 (mean change: monotherapy −3.40, combination therapy −3.46), with no significant difference between groups (P = 0.46). The proportion of patients who achieved DAS28-ESR or Clinical Disease Activity Index remission or ACR 20/50/70/90 responses was similar between groups. Overall, 13.9% of patients withdrew—6.2% for safety reasons and 1.6% for insufficient therapeutic response; 5.8% of patients experienced one or more serious adverse events [14.6/100 patient-years (PY)]; six deaths occurred (0.64/100 PY). In a common framework of 11 studies in 22 countries, this phase 4 study programme confirmed TCZ-SC’s known efficacy and safety profile with comparable effects as monotherapy and in combination with csDMARDs. ClinicalTrials.gov (http://www.clinicaltrials.gov) NCT01941940, NCT01941095, NCT01951170, NCT01987479, NCT01988012, NCT01995201, NCT02001987, NCT02011334, NCT02031471, NCT02046603 and NCT02046616." @default.
- W2775698961 created "2017-12-22" @default.
- W2775698961 creator A5004025365 @default.
- W2775698961 creator A5015032522 @default.
- W2775698961 creator A5032299320 @default.
- W2775698961 creator A5053288231 @default.
- W2775698961 creator A5075369229 @default.
- W2775698961 creator A5082221558 @default.
- W2775698961 creator A5083583562 @default.
- W2775698961 creator A5087200876 @default.
- W2775698961 date "2017-12-13" @default.
- W2775698961 modified "2023-10-18" @default.
- W2775698961 title "Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries" @default.
- W2775698961 cites W1608734376 @default.
- W2775698961 cites W1838548883 @default.
- W2775698961 cites W1991229597 @default.
- W2775698961 cites W2008138329 @default.
- W2775698961 cites W2021469201 @default.
- W2775698961 cites W2054059257 @default.
- W2775698961 cites W2063485775 @default.
- W2775698961 cites W2075982900 @default.
- W2775698961 cites W2096862304 @default.
- W2775698961 cites W2097874407 @default.
- W2775698961 cites W2113398090 @default.
- W2775698961 cites W2114308202 @default.
- W2775698961 cites W2150952126 @default.
- W2775698961 cites W2163480494 @default.
- W2775698961 cites W2177530838 @default.
- W2775698961 cites W2327897261 @default.
- W2775698961 cites W2523519404 @default.
- W2775698961 cites W2564331065 @default.
- W2775698961 doi "https://doi.org/10.1093/rheumatology/kex443" @default.
- W2775698961 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5965097" @default.
- W2775698961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29635639" @default.
- W2775698961 hasPublicationYear "2017" @default.
- W2775698961 type Work @default.
- W2775698961 sameAs 2775698961 @default.
- W2775698961 citedByCount "29" @default.
- W2775698961 countsByYear W27756989612018 @default.
- W2775698961 countsByYear W27756989612019 @default.
- W2775698961 countsByYear W27756989612020 @default.
- W2775698961 countsByYear W27756989612021 @default.
- W2775698961 countsByYear W27756989612022 @default.
- W2775698961 countsByYear W27756989612023 @default.
- W2775698961 crossrefType "journal-article" @default.
- W2775698961 hasAuthorship W2775698961A5004025365 @default.
- W2775698961 hasAuthorship W2775698961A5015032522 @default.
- W2775698961 hasAuthorship W2775698961A5032299320 @default.
- W2775698961 hasAuthorship W2775698961A5053288231 @default.
- W2775698961 hasAuthorship W2775698961A5075369229 @default.
- W2775698961 hasAuthorship W2775698961A5082221558 @default.
- W2775698961 hasAuthorship W2775698961A5083583562 @default.
- W2775698961 hasAuthorship W2775698961A5087200876 @default.
- W2775698961 hasBestOaLocation W27756989611 @default.
- W2775698961 hasConcept C126322002 @default.
- W2775698961 hasConcept C17923572 @default.
- W2775698961 hasConcept C197934379 @default.
- W2775698961 hasConcept C2776999253 @default.
- W2775698961 hasConcept C2777178219 @default.
- W2775698961 hasConcept C2777575956 @default.
- W2775698961 hasConcept C71924100 @default.
- W2775698961 hasConceptScore W2775698961C126322002 @default.
- W2775698961 hasConceptScore W2775698961C17923572 @default.
- W2775698961 hasConceptScore W2775698961C197934379 @default.
- W2775698961 hasConceptScore W2775698961C2776999253 @default.
- W2775698961 hasConceptScore W2775698961C2777178219 @default.
- W2775698961 hasConceptScore W2775698961C2777575956 @default.
- W2775698961 hasConceptScore W2775698961C71924100 @default.
- W2775698961 hasFunder F4320309432 @default.
- W2775698961 hasIssue "3" @default.
- W2775698961 hasLocation W27756989611 @default.
- W2775698961 hasLocation W27756989612 @default.
- W2775698961 hasLocation W27756989613 @default.
- W2775698961 hasLocation W27756989614 @default.
- W2775698961 hasLocation W27756989615 @default.
- W2775698961 hasLocation W27756989616 @default.
- W2775698961 hasLocation W27756989617 @default.
- W2775698961 hasLocation W27756989618 @default.
- W2775698961 hasOpenAccess W2775698961 @default.
- W2775698961 hasPrimaryLocation W27756989611 @default.
- W2775698961 hasRelatedWork W1996887190 @default.
- W2775698961 hasRelatedWork W2104386994 @default.
- W2775698961 hasRelatedWork W2156283049 @default.
- W2775698961 hasRelatedWork W2232273633 @default.
- W2775698961 hasRelatedWork W2316954211 @default.
- W2775698961 hasRelatedWork W2761967325 @default.
- W2775698961 hasRelatedWork W2939394019 @default.
- W2775698961 hasRelatedWork W2970100988 @default.
- W2775698961 hasRelatedWork W4251265868 @default.
- W2775698961 hasRelatedWork W2899737214 @default.
- W2775698961 hasVolume "57" @default.
- W2775698961 isParatext "false" @default.
- W2775698961 isRetracted "false" @default.
- W2775698961 magId "2775698961" @default.
- W2775698961 workType "article" @default.